We found that combining maternal factors (age, pregestational BMI, history of GDM, history of preeclampsia, family history of DM, chronic hypertension, and MAP) and prenatal screening biomarkers (PAPP-A and PLGF) could identify 73% of cases of GDM. This evidence concerns the gene PGF and gestational diabetes.